
Genetic Technologies Limited GENE
Geschäftsbericht 2022
hinzugefügt 30.08.2022
Genetic Technologies Limited P/CF 2011-2026 | GENE
P/CF Jährlich Genetic Technologies Limited
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.63 K | -2.71 K | -2.91 K | -1.91 | -3.53 | -1.83 | -3.23 | -2.47 | -1.58 | -5.3 | -7.43 | 38.9 |
Alle Zahlen in AUD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 38.9 | -2.91 K | -603 |
P/CF anderer Aktien in der Diagnostik & Forschung
| Name | P/CF | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
26.1 | - | -6.23 % | $ 30.6 M | ||
|
Fulgent Genetics
FLGT
|
22.2 | $ 15.96 | 5.63 % | $ 483 M | ||
|
Burning Rock Biotech Limited
BNR
|
-40.2 | $ 16.76 | 1.09 % | $ 177 M | ||
|
Castle Biosciences
CSTL
|
7.33 | $ 19.83 | 3.07 % | $ 575 M | ||
|
Agilent Technologies
A
|
28.3 | $ 115.62 | -2.55 % | $ 35.1 B | ||
|
Akumin
AKU
|
1.15 | - | -17.87 % | $ 25.9 M | ||
|
Aspira Women's Health
AWH
|
-1.41 | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
-0.826 | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
-0.447 | - | -13.05 % | $ 7.29 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
-47.7 | - | - | $ 562 M | ||
|
CareDx, Inc
CDNA
|
23.6 | $ 21.82 | 1.77 % | $ 1.16 B | ||
|
Chembio Diagnostics
CEMI
|
-0.991 | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
-0.541 | - | - | $ 9.42 M | ||
|
Lantheus Holdings
LNTH
|
13.1 | $ 93.06 | 2.26 % | $ 6.28 B | ||
|
HTG Molecular Diagnostics
HTGM
|
-0.162 | - | -20.0 % | $ 1.06 M | ||
|
Medpace Holdings
MEDP
|
18.2 | $ 424.0 | -1.1 % | $ 12.2 B | ||
|
Co-Diagnostics
CODX
|
-0.201 | $ 2.53 | 31.09 % | $ 3.37 M | ||
|
Myriad Genetics
MYGN
|
227 | $ 4.29 | 4.89 % | $ 397 M | ||
|
NeoGenomics
NEO
|
284 | $ 8.96 | -1.21 % | $ 1.15 B | ||
|
National Research Corporation
NRC
|
11.9 | $ 18.75 | 0.11 % | $ 420 M | ||
|
Global Cord Blood Corporation
CO
|
0.396 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-17.1 | - | 1.08 % | $ 308 M | ||
|
Genetron Holdings Limited
GTH
|
-2.94 | - | 0.12 % | $ 80.1 M | ||
|
Natera
NTRA
|
-12.3 | $ 194.24 | -11.64 % | $ 19.1 B | ||
|
DermTech
DMTK
|
-0.551 | - | -11.32 % | $ 2.94 M | ||
|
Charles River Laboratories International
CRL
|
10.4 | $ 177.62 | -2.23 % | $ 8.8 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
21.8 | - | - | $ 10.7 B | ||
|
Enzo Biochem
ENZ
|
-0.00219 | - | -8.98 % | $ 14.8 K | ||
|
Koninklijke Philips N.V.
PHG
|
26.5 | $ 27.21 | 0.18 % | $ 25.8 B | ||
|
Exact Sciences Corporation
EXAS
|
39.7 | - | - | $ 19.8 B | ||
|
Personalis
PSNL
|
-5.75 | $ 5.98 | -0.17 % | $ 534 M | ||
|
Guardant Health
GH
|
-72.7 | $ 95.7 | 3.73 % | $ 12 B | ||
|
Senseonics Holdings
SENS
|
-5.93 | $ 5.03 | -6.16 % | $ 210 M | ||
|
Soleno Therapeutics
SLNO
|
44.5 | $ 52.95 | - | $ 2.69 B | ||
|
Heska Corporation
HSKA
|
-38.7 | - | - | $ 1.31 B | ||
|
ICON Public Limited Company
ICLR
|
12.9 | $ 124.49 | -0.41 % | $ 10.3 B | ||
|
Illumina
ILMN
|
19.6 | $ 141.88 | 2.29 % | $ 22.6 B | ||
|
Interpace Biosciences
IDXG
|
1.26 | $ 1.95 | -2.5 % | $ 8.63 M | ||
|
QIAGEN N.V.
QGEN
|
12.6 | - | - | $ 10.6 B | ||
|
Trinity Biotech plc
TRIB
|
-46.3 | $ 0.61 | 2.52 % | $ 219 M | ||
|
Twist Bioscience Corporation
TWST
|
-32.8 | $ 56.85 | -2.89 % | $ 3.4 B | ||
|
Biomerica
BMRA
|
-1.87 | $ 2.15 | -2.05 % | $ 4.94 M | ||
|
Thermo Fisher Scientific
TMO
|
25.1 | $ 465.0 | -1.99 % | $ 175 B | ||
|
Laboratory Corporation of America Holdings
LH
|
14.6 | $ 254.12 | -1.52 % | $ 21.1 B | ||
|
Celcuity
CELC
|
-35 | $ 131.06 | 0.27 % | $ 6.13 B | ||
|
Motus GI Holdings
MOTS
|
-0.0884 | - | -34.28 % | $ 263 K | ||
|
Waters Corporation
WAT
|
30.1 | $ 355.13 | 1.32 % | $ 21.1 B | ||
|
Neogen Corporation
NEOG
|
17.5 | $ 9.05 | -2.16 % | $ 1.96 B | ||
|
Quest Diagnostics Incorporated
DGX
|
12.4 | $ 187.39 | -1.82 % | $ 20.8 B |